1,082
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Study on enhanced lymphatic exposure of polyamidoamin-alkali blue dendrimer for paclitaxel delivery and influence of the osmotic pressure on the lymphatic targeting

, , , , &
Pages 2617-2629 | Received 15 Feb 2015, Accepted 13 Apr 2015, Published online: 28 May 2015

References

  • Alex JC, Weaver DL, Fairbank JT, et al. (1993). Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 2:303–8
  • Benedetti-Pancini P, Maneschi F, Scambia G, et al. (1996). Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systemic pelvic and aortic lymphadenectomy. Gynecol Oncol 62:19–24
  • Buhleier E, Wehner W, Vogtle F. (1978). Cascade- and nonskid-chain-like syntheses of molecular cavity topologies. Synthesis 2:155–8
  • Chen H, Banaszak Holl M, Orr BG, et al. (2003). Interaction of dendrimers (artificial proteins) with biological hydroxyapatite crystals. J Dent Res 82:443–8
  • De Campos JDF, Da Silva JB, Beck ARM, et al. (2013). Subcutaneous administration technique of low-molecular-weight heparins: an integrative review. Clin Nurs Stud 1:36--40
  • Dowlatshahi K, Fan M, Snider HC, Habib FA. (1997). Lymph node micro metastases from breast carcinoma: reviewing the dilemma. Cancer 80:1188–97
  • Jain RK. (1989). Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst 81:570–6
  • Kaminskas LM, Porter CJH. (2011). Targeting the lymphatics using dendritic polymers (dendrimers). Adv Drug Deliv Rev 63:890–900
  • Kobayashi H, Kawamoto S, Sakai Y, et al. (2004). Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nanosize paramagnetic contrast agent. J Natl Cancer Inst 96:703–8
  • Kobayashi H, Koyama Y, Barrett T, et al. (2007). Multimodal nanoprobes for radionuclide and fivecolor near-infrared optical lymphatic imaging. ACS Nano 1:258–64
  • Kobayashi H, Sato N, Hiraga A, et al. (2001). 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties. Magn Reson Med 45:454–60
  • Kodama Y, Inokuchi K, Okamura T. (1979). Tumor cell aggregation and mode of cancer spread in linitis plastics type of gastric carcinoma. Gann 70:721–9
  • Kumer D, Tomar RS, Deolia SK, et al. (2007). Isolation and characterization of degradation impurities in docetaxel drug substance and its formulation. J Pharm Biomed 43:1228–35
  • Lei XG, Jockusch S, Turro NJ, et al. (2008). EPR characterization of gadolinium (III)-containing-PAMAM-dendrimers in the absence and in the presence of paramagnetic probes. J Colloid Interface Sci 322:457–64
  • Leong SP, Cady B, Jablons DM, et al. (2006). Clinical patterns of metastasis. Cancer Metast Rev 25:221–32
  • Lim J, Chouai A, Lo ST, et al. (2009). Design, synthesis, characterization, and biological evaluation of triazine dendrimers bearing paclitaxel using ester and ester/disulfide linkages. Bioconjug Chem 20:2154–61
  • McDonald TA, Zepeda ML, Tomlinson MJ, et al. (2010). Subcutaneous administration of biotherapeutics: current experience in animal models. Curr Opin Mol Ther 12:461–70
  • Mitra S, Gaur U, Ghosh PC, Maitra AN. (2001). Tumor targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 74:317–23
  • Moghimi SM, Szebeni J. (2003). Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42:463–78
  • Morton DL, Wen DR, Wong JH, et al. (1992). Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–9
  • Mounzer R, Shakarin P, Papademetris X, et al. (2007). Dynamic imaging of lymphatic vessels and lymph nodes using a bimodal nanoparticulate contrast agent. Lymphat Res Biol 5:151–8
  • Nishioka Y, Yoshino H. (2001). Lymphatic targeting with nanoparticulate system. Adv Drug Deliv Rev 47:55–64
  • Shimoda H, Takahashi Y, Kajiwara T, Kato S. (2003). Demonstration of the rat lymphatic vessels using immunohistochemistry and in situ hybridization for 5′-nucleotidase. Biomed Res 24:51–7
  • Sleeman J, Schmid A, Thiele W. (2009). Tumor lymphatics. Semin Cancer Biol 19:285–97
  • Tam JP, Spetzler JC. (2001). Synthesis and application of peptide dendrimers as protein mimetics. Curr Protoc Protein Sci Chapter 18:Unit18.5. DOI: 10.1002/0471140864.ps1805s17
  • Tomalia DA, Baker H, Dewald JR, et al. (1985). A new class of polymers: starburst-dendritic macromolecules. Polym J 17:117–32
  • Tomalia DA, Reyna LA, Svenson S. (2007). Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans 3:61–7
  • Xie Y, Bagby TR, Cohen MS, Forrest ML. (2009). Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies. Expert Opin Drug Deliv 6:785–92
  • Yang H, Lopina ST. (2007). Stealth dendrimers for antiarrhythmic quinidine delivery. J Mater Sci Mater M. 18:2061–5
  • Yang R, Xia SX, Ye TT, et al. (2014). Synthesis of a novel polyamidoamine dendrimer conjugating with alkali blue as a lymphatic tracer and study on the lymphatic targeting in vivo. Drug Deliv Early Online: 1--11. DOI: http://dx.doi.org/10.3109/10717544.2014.979515
  • Ye TT, Zhang WJ, Sun MS, et al. (2014). Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting. Int J Pharm 471:245–57

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.